Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

668 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Capecitabine for the treatment of pancreatic cancer.
Siddiqui NS, Godara A, Byrne MM, Saif MW. Siddiqui NS, et al. Among authors: saif mw. Expert Opin Pharmacother. 2019 Mar;20(4):399-409. doi: 10.1080/14656566.2018.1560422. Epub 2019 Jan 16. Expert Opin Pharmacother. 2019. PMID: 30649964 Review.
The safety of lanreotide for neuroendocrine tumor.
Godara A, Siddiqui NS, Byrne MM, Saif MW. Godara A, et al. Among authors: saif mw. Expert Opin Drug Saf. 2019 Jan;18(1):1-10. doi: 10.1080/14740338.2019.1559294. Epub 2018 Dec 24. Expert Opin Drug Saf. 2019. PMID: 30582380 Review.
Masitinib in treatment of pancreatic cancer.
Waheed A, Purvey S, Saif MW. Waheed A, et al. Among authors: saif mw. Expert Opin Pharmacother. 2018 May;19(7):759-764. doi: 10.1080/14656566.2018.1459566. Epub 2018 Apr 11. Expert Opin Pharmacother. 2018. PMID: 29638149
Second line treatment options for pancreatic cancer.
Passero FC Jr, Saif MW. Passero FC Jr, et al. Among authors: saif mw. Expert Opin Pharmacother. 2017 Oct;18(15):1607-1617. doi: 10.1080/14656566.2017.1369955. Epub 2017 Oct 6. Expert Opin Pharmacother. 2017. PMID: 28820270 Review.
668 results